Game Over for RSV?

• 2023

  Log in to bookmark this resource.

  Log in
• Madison Strine; Craig Wilen
PMID: 37276355DOI: https://dx.doi.org/10.1126/sciimmunol.adi8764

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This letter comments on a study by D. Wilkins and colleagues and concludes that passive immunization with nirsevimab protects infants from severe respiratory syncytial virus disease without impairing the immune response to natural infection.

---

Tags

Focus Area: Infectious Disease

Keywords: Immunization, Passive; Infant; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Antibodies, Monoclonal, Humanized

Emergency Management Stage: Preparedness (Prevention / Protection)

Audiences: Nurses; Physicians; Public Health Professionals

Format: Journal Article

Media Type: Website

Institutions: Yale University

Institution Type: Academic

Language: English

Bundles: Nirsevimab Library

---

More like this

Game Over for RSV? 2023 · Yale University Chemical-Biological Terrorism and Its Impact on Children [2020] 2020 · Harvard Medical School, Boston Children's Hospital, Yale University, Children's Hospital Colorado, University of Colorado, American Academy of Pediatrics (AAP) The 2021 Toolkit for Emergency Preparedness and Mitigation to Combat Surge of Pediatric COVID-19 Patients in India: The World Health Organization Collaborating Center for Emergency and Trauma in South East Asia Recommendations 2021 · Florida State University, University of Nevada, Las Vegas, Manipal Academy of Higher Education, State University of New York Downstate Health Sciences University

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---